Research Library
Thymosin Alpha-1 research
6 articles to explore, with links to 9 original sources.
About Thymosin Alpha-1
Thymosin alpha-1 is a twenty-eight-residue peptide used in research on immune-related signaling.
Understand the science
How a 2026 Study Linked Thymosin Alpha 1 to Immune Recognition in Mice
Thymosin alpha-1 is a peptide studied for effects on immunity. A 2026 study by Yiting Wei and colleagues examined why certain immune responses to tumors were weak after chemotherapy. The paper combined observations from human samples with experiments in cells and mice.
1 source (2026)
Explore study findings
What a Large Sepsis Trial Found About Thymosin Alpha 1
Thymosin alpha-1 is a 28-amino-acid peptide studied in immune regulation, and thymalfasin is a drug form of it. The phase 3 TESTS trial asked whether adding thymosin alpha-1 to the care of adults with sepsis reduced death within 28 days.
3 sources (2025, 2026)
Check methods and identity
What a 2026 Thymalfasin Sepsis Registry Entry Plans to Measure
Thymosin alpha-1 is an immune-related peptide, and thymalfasin is its drug form. An October 2026 trial registration describes a study in adults with sepsis and signs of reduced immune function. It records a research plan and does not report a result.
1 source (2026)
Why Thymosin Alpha 1 Needs Its Own Identity and Regulatory Evidence
Thymosin alpha-1 is a 28-amino-acid peptide studied in immune biology. It is distinct from thymosin beta-4 and from materials described as fragments of beta-4. An article about one should not inherit the clinical or regulatory evidence for the other.
3 sources (2024, 2026)
Interpret the evidence
Why Lymphocyte Counts Cannot Tell the Whole Story in Cancer Research
Thymosin alpha-1 is a peptide investigated in this context. A 2025 study examined blood counts in people with advanced cancer who received thymosin alpha-1 before a regimen involving radiation and immunotherapy. Its publication falls within the requested year.
1 source (2025)
What a Thymalfasin Vaccine Study Registration Can and Cannot Show
Thymosin alpha-1 is an immune-related peptide, and thymalfasin is a defined drug form. A registry record updated in 2026 describes a study involving older adults receiving a COVID-19 vaccine booster.
1 source (2026)
